Quantbot Technologies LP Sells 7,666 Shares of Afya Limited (NASDAQ:AFYA)

Quantbot Technologies LP decreased its holdings in Afya Limited (NASDAQ:AFYA) by 57.8% in the 4th quarter, HoldingsChannel reports. The firm owned 5,602 shares of the company’s stock after selling 7,666 shares during the quarter. Quantbot Technologies LP’s holdings in Afya were worth $89,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of AFYA. State Street Corp raised its holdings in shares of Afya by 118.2% in the third quarter. State Street Corp now owns 73,098 shares of the company’s stock valued at $1,248,000 after buying an additional 39,592 shares during the last quarter. Point72 Asset Management L.P. bought a new position in shares of Afya in the third quarter worth about $842,000. Erste Asset Management GmbH acquired a new position in shares of Afya during the third quarter worth approximately $822,000. Van ECK Associates Corp grew its stake in shares of Afya by 41.9% during the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company’s stock valued at $154,000 after purchasing an additional 2,856 shares during the last quarter. Finally, Centiva Capital LP acquired a new stake in shares of Afya in the third quarter valued at approximately $213,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. The Goldman Sachs Group assumed coverage on Afya in a report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price objective on the stock. Citigroup reaffirmed a “sell” rating and set a $15.00 price target (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. JPMorgan Chase & Co. lowered their price objective on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a research report on Friday, January 17th. Finally, Morgan Stanley downgraded shares of Afya from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. According to data from MarketBeat, Afya currently has an average rating of “Reduce” and a consensus target price of $17.60.

Afya Trading Up 0.3 %

Shares of Afya stock opened at $17.93 on Tuesday. Afya Limited has a 12-month low of $14.52 and a 12-month high of $20.06. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $17.01 and its 200-day moving average is $16.56. The stock has a market cap of $1.68 billion, a P/E ratio of 14.46, a P/E/G ratio of 0.29 and a beta of 0.82.

Afya Dividend Announcement

The business also recently disclosed a — dividend, which will be paid on Friday, April 4th. Shareholders of record on Wednesday, March 26th will be given a dividend of $0.232 per share. The ex-dividend date of this dividend is Wednesday, March 26th. Afya’s dividend payout ratio (DPR) is 17.69%.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.